Krishna Institute of Medical Sciences Share Price Today | Stock Price & Krishna Institute of Medical Sciences Share Screener
As of November 18, 2026, the live Krishna Institute of Medical Sciences share price (NSE: KIMS) is ₹759.00 on NSE and ₹756.30 on BSE, down 1.21% from the previous close, with shares trading between ₹750.75 and ₹772.15 in today's trading session, and a 52-week range of ₹582.10–₹850.65. Track Krishna Institute of Medical S networth to gauge the company's total market size. Use the Krishna Institute of Medical Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Krishna Institute of Medical Sciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹1,087 and net income of ₹33, with EBITDA of ₹208, an operating margin of 18.0% and a profit margin of 3.0%.
Krishna Institute of Medical Sciences Share Price Chart
Track the current stock price of Krishna Institute of Medical Sciences with an interactive chart. Analyse KIMS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Krishna Institute of Medical Sciences stock quote in one place.
The quote of ₹759.00 sits between the 52-week low of ₹582.10 and the 52-week high of ₹850.65, and the latest session moved -1.21% from the previous close.
Krishna Institute of Medical Sciences Company Profile - Fundamental Screener
Screen Krishna Institute of Medical Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KIMS shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Services industry, with Bhaskara Rao Bollineni listed as chairperson or CEO, and it trades under ISIN INE967H01025.
Business Overview
Krishna Institute of Medical Sciences Limited (KIMS) is an Indian healthcare company operating 12 multispecialty hospitals under the KIMS Hospitals brand. With over 4,000 beds, KIMS provides tertiary and quaternary healthcare services across more than 40 specialties and super specialties. The company's network includes hospitals in Telangana, Andhra Pradesh, and...more
Company Details
Classification
Identifiers and Leadership
Krishna Institute of Medical Sciences Balance Sheet Screener
Screen KIMS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹7,759, up from ₹5,736 in 2025.
Latest statistics put total assets at ₹7,759 and shareholder funds at ₹2,559, with a leverage ratio of 1.55.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
Assets |
|||||||||
| Total Assets | 7,759 | 5,736 | 3,852 | 2,941 | 1,907 | 1,436 | 1,196 | 1,118 | 958 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 5,710 | 3,349 | 2,434 | 1,766 | 1,005 | 931 | 916 | 863 | 755 |
Liabilities |
|||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3,961 | 2,481 | 1,307 | 707 | 282 | 282 | 366 | 351 | 347 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||||
| Total Equity | 2,559 | 2,419 | 2,093 | 1,938 | 1,411 | 876 | 611 | 566 | -138 |
| Share Capital | 80 | 80 | 80 | 80 | 80 | 78 | 75 | 75 | 50 |
| Reserves & Surplus | 2,167 | 2,058 | 1,748 | 1,590 | 1,307 | 786 | 523 | 466 | -209 |
Krishna Institute of Medical Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Krishna Institute of Medical Sciences income statement and profit fundamentals. Analyze KIMS quarterly results. Krishna Institute of Medical Sciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹1,087 and net profit was ₹33, equal to earnings per unit of ₹1.06, at an operating margin of 18%.
In that period expenses were ₹879, interest cost ₹68 and tax ₹22. The next period listed, 2026-Jun, shows revenue of ₹1,197 and net profit of ₹37.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 1,087 | 1,197 | 1,376 | 812 | 879 | 965 | 1,003 | 638 | 693 | 782 | 790 | 581 | 609 | 655 | 609 |
| Expenses | 879 | 956 | 1,085 | 599 | 679 | 757 | 799 | 475 | 509 | 559 | 585 | 413 | 449 | 475 | 459 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 208 | 241 | 292 | 213 | 200 | 208 | 204 | 163 | 184 | 223 | 205 | 168 | 160 | 180 | 150 |
| Operating Profit % | 18.00% | 19.00% | 19.00% | 25.00% | 22.00% | 21.00% | 20.00% | 25.00% | 26.00% | 28.00% | 24.00% | 28.00% | 26.00% | 27.00% | 24.00% |
| Depreciation | 85 | 101 | 121 | 53 | 53 | 66 | 79 | 46 | 39 | 41 | 45 | 35 | 32 | 33 | 35 |
| Interest | 68 | 83 | 66 | 27 | 33 | 45 | 57 | 16 | 18 | 20 | 26 | 5 | 9 | 9 | 12 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 55 | 57 | 106 | 134 | 114 | 97 | 69 | 100 | 127 | 162 | 135 | 127 | 119 | 139 | 102 |
| Tax | 22 | 19 | 31 | 28 | 29 | 25 | 17 | 29 | 32 | 42 | 42 | 29 | 32 | 37 | 26 |
| Net Profit | 33 | 37 | 75 | 106 | 85 | 72 | 52 | 72 | 95 | 121 | 93 | 99 | 87 | 101 | 77 |
| EPS | 1.06 | 1.04 | 1.79 | 2.54 | 1.96 | 1.67 | 1.33 | 8.18 | 10.82 | 2.68 | 2.22 | 11.65 | 10.10 | 11.50 | 8.98 |
Krishna Institute of Medical Sciences Cash Flow Screener - Liquidity Fundamentals
Screen KIMS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹511, and net cash flow was an outflow of ₹1.
Over the same period, investing activities used ₹1,452 and financing activities provided ₹940.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 511 | 582 | 521 | 432 | 324 | 356 | 202 | 134 | 106 | 82 |
| Investing Activities | -1,452 | -1,116 | -753 | -416 | -412 | -354 | -125 | -110 | -64 | -100 |
Financing and Net Cash | ||||||||||
| Financing Activities | 940 | 543 | 217 | 20 | 61 | 10 | -44 | -27 | -39 | 24 |
| Net Cash Flow | -1 | 9 | -15 | 36 | -27 | 12 | 33 | -3 | 3 | 5 |
Krishna Institute of Medical Sciences Shareholding Pattern Screener
See Krishna Institute of Medical Sciences shareholding pattern with promoter, FII, and DII holdings. Check Krishna Institute of Medical Sciences promoter holding and ownership changes for KIMS on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 34.11%, foreign institutions 14.57%, domestic institutions 32.50% and the public 11.84%, spread across 93,333 shareholders.
The shareholder count was 93,333 in 2026-Mar, compared with 95,710 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 34.11% | 32.50% | 32.66% | 38.82% | 34.11% | 34.11% | 34.11% | 38.82% |
Institutional Investors | ||||||||
| FII Holding | 14.57% | 14.44% | 15.01% | 15.45% | 15.54% | 15.03% | 14.33% | 16.73% |
| DII Holding | 32.50% | 34.59% | 33.22% | 31.95% | 31.66% | 32.12% | 32.71% | 33.13% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.84% | 11.22% | 11.83% | 11.24% | 11.58% | 11.72% | 11.76% | 10.73% |
| Other Holding | 6.98% | 7.25% | 7.28% | 2.54% | 7.11% | 7.03% | 7.09% | 0.59% |
| Shareholder Count | 93,333 | 95,710 | 95,609 | 101,895 | 108,955 | 104,872 | 101,599 | 69,092 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Krishna Institute of Medical Sciences. Krishna Institute of Medical Sciences dividend yield can be compared with peers and other stocks in the market.
Krishna Institute of Medical Sciences Stock Index Membership - Nifty & Sensex
See which indices include Krishna Institute of Medical Sciences stock. Check KIMS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 16 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.
Complete Index List
Krishna Institute of Medical Sciences Market Events Screener - Corporate Actions
Get Krishna Institute of Medical Sciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Krishna Institute of Medical Sciences stock events that may affect KIMS share price, along with derivatives, futures and options activity and sector gainers.
14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 4, 2026, with a record date of November 4, 2026.
It is followed by Annual General Meeting dated August 27, 2026 and Quarterly Result Announcement dated August 3, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-04 | 2026-11-04 | Quarterly Result Announcement | NA | 9.66% |
| 2026-08-27 | 2026-08-27 | Annual General Meeting | NA | -0.72% |
| 2026-08-03 | 2026-08-03 | Quarterly Result Announcement | NA | 0.53% |
| 2026-07-09 | 2026-07-09 | Extraordinary General Meeting | NA | 2.68% |
| 2026-05-15 | 2026-05-15 | Quarterly Result Announcement | NA | 14.40% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 2.17% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -0.01% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | 16.13% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | -2.98% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -3.40% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 7.11% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 9.57% |
| 2024-09-13 | 2024-09-13 | Split | 2:10 | 30.09% |
| 2024-08-29 | 2024-08-29 | Annual General Meeting | NA | 28.84% |
Krishna Institute of Medical Sciences Competitors Screener - Peer Stocks Comparison
Screen KIMS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 125,272 | 53.90 | 25,420 | 15.58% | 2,003 | 61.89 |
| Max Healthcare Institute | 100,339 | 71.20 | 8,536 | 18.82% | 1,442 | 76.17 |
| Manipal Health Enterprises | 92,333 | 104.20 | 10,521 | 25.80% | 917 | 60.80 |
| Aster DM Quality Care | 64,325 | 116.10 | 4,769 | 11.25% | 427 | 57.55 |
| Fortis Healthcare | 60,910 | 57.00 | 9,179 | 16.93% | 1,064 | 57.30 |
| Narayana Hrudayalaya | 38,984 | 45.00 | 7,996 | 43.43% | 811 | 61.49 |
| Global Health | 38,830 | 62.80 | 4,509 | 19.56% | 554 | 64.64 |
| Krishna Institute of Medical Sciences | 32,269 | 163.00 | 3,931 | 28.16% | 242 | 66.73 |
| Dr. Lal Path Labs | 33,237 | 57.20 | 2,864 | 12.11% | 510 | 54.28 |
| Syngene International | 17,533 | 95.70 | 3,809 | 2.56% | 317 | 61.78 |
Krishna Institute of Medical Sciences Company Announcements - News & Reports Screener
Screen KIMS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 16, 2026.
The next most recent announcements are dated November 13, 2026 and November 12, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-16 | KIMS Swastha Private Limited (KSPL) Wholly-Owned Subsidiary Of The Krishna Institute Of Medical Sciences Limited (Company) Has Entered Into An Operations And Management Agreement With LOVR Institute Of Medical Sciences Limited | - |
| 2026-11-13 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-11-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-11-04 | Deviation Report - QIP | - |
| 2026-11-04 | Deviation Report - Preferential Allotment | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-11-04 | Result For The Quarter Ended 30.09.2026 | - |
| 2026-11-04 | Board Meeting Outcome for Outcome Of Board Meeting Held On 04Th November 2026 Pursuant To Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-11-01 | General Update | - |
| 2026-10-29 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-10-29 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-10-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹759.00, within a 52-week range of ₹582.10 to ₹850.65. The P/E ratio is 163.00 and the P/B ratio is 8.17, with earnings per unit of ₹6.03. Market capitalisation stands at ₹32,269.10 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.